Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Practice volume was low and resulted in a lack of participant accrual
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Researchers are studying how vein mapping impacts patient outcomes and satisfaction after facial injection procedures.
Facial Botox/filler injections carry risk of puncturing superficial veins, leading to bruising and pain. Our study will investigate the utility of non-invasive vein imaging (specifically near-infrared light reflection) on the incidence of pain/bruising/hematoma and patient satisfaction after facial injections.
The current standard of care for facial injection procedures does not involve any modality of facial venous mapping. Vein mapping is a non-invasive, simple task that takes very little time to conduct. One risk is patient time, however maximum extra time needed will be 5 minutes during the clinical visit. This potential extra time in mind, the benefits far outweigh the risks.
Two cohorts of patients will be prospectively compared following randomization, those who did have pre-procedure venous mapping prior to injection versus those who did not. Data will be analyzed with regard to bruising and swelling following injection, as well as other potential complications such as hematoma or infection, along with patient satisfaction survey information.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Goup | No Intervention | Subjects will undergo clinically indicated facial injection procedures per standard of care without venous mapping | |
| Intervention Group | Experimental | Subjects will undergo clinically indicated facial injection procedure with pre-procedural facial venous mapping by Accuvein® Veinfinder |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Accuvein® Veinfinder | Device | Near-infrared light reflection utilized by healthcare providers to see superficial veins under the skin. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient satisfaction | Measured using the self-reported FACE-Q satisfaction score, using a scale of 1=definitely disagree and 4=definitely agree | Approximately 7-10 days following the procedure |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of Bruising/Hematoma | Number of subjects to experience bruising/hematoma post facial injection procedure | Approximately 7-10 days following the procedure |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| William Casey III, MD | Mayo Clinic | Principal Investigator |
Not provided
Not provided
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided